Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome

Medicine & Life Sciences

• Pulmonary Surfactant-Associated Proteins 100%
• Newborn Respiratory Distress Syndrome 88%
• Dexamethasone 58%
• Staphylococcal Protein A 27%
• Surface-Active Agents 25%
• Premature Infants 23%
• Artificial Respiration 15%
• Respiratory Distress Syndrome In Premature Infants 14%
• Pulmonary Surfactant-Associated Protein D 11%
• Pulmonary Surfactant-Associated Protein A 11%
• Pulmonary Ventilation 10%
• Therapeutics 10%
• Weaning 8%
• Lung 8%
• Carbon Dioxide 8%
• Double-Blind Method 7%
• Albumins 6%
• Oxygen 5%
• Placebos 5%
• Pressure 5%
• Control Groups 4%